A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy

Volume: 79, Issue: 17, Pages: 4315 - 4323
Published: Sep 1, 2019
Abstract
Cancer scientists and clinicians are mourning the death of one of the most accomplished members of their community: Dr. John Mendelsohn. He was a pioneer in targeted cancer therapy and was instrumental for the discovery and deployment of the first antagonist epidermal growth factor receptor (EGFR) therapeutic antibodies, broadening the concept of targeted EGFR therapy to encompass other receptor tyrosine kinases, such as HER2, and developing...
Paper Details
Title
A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy
Published Date
Sep 1, 2019
Volume
79
Issue
17
Pages
4315 - 4323
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.